… of circulating melanoma cells (CMCs) may facilitate the development of more effective
therapies for metastatic melanoma patients. In this study CD146+ cells were immunomagnetically …

… MUC18 in metastatic melanoma cells significantly reduced … metastatic melanoma cells are
incapable of performing. The upregulation of VE-cadherin in highly metastatic melanoma cells …

… Melanocytic cells from various stages of tumor progression have been little characterized. …
of 3 primary melanoma cell lines and a total of 16 metastatic melanoma cell lines from the …

… generating melanoma cell lines in order to develop new therapies for metastatic melanoma,
… that correlated with the invasive potential of metastatic melanoma cell lines in vitro. This is …

… metastatic melanoma cell survival, particularly under starvation condition, supporting the
evidence that tumor cells … that human metastatic melanoma cells may eat live T cells, which are …

… melanoma cell line (SB-2) with low metastatic potential that did not express detectable levels
of MCAM/MUC18. The SB-2 cell … into a highly metastatic melanoma cell line lacking the wild…

… High-level expression of TF thus characterizes these metastatic melanoma cells. Indirect
immunofluorescence was used to assess whether TF was expressed on the tumor cell surface …

… Melanoma-initiating (tumorigenic) cells were reported to be rare based on the observation
that only 1 in 1,090,000 human metastatic melanoma cells … freshly dissociated melanoma cells …

… cells is regulated by adhesion molecules, matrix metalloproteases, … Melanoma cells
may travel along external vessel lattices. After settling in the metastatic sites, melanoma cells …

… mimicry by aggressive human melanoma cells. In the present study, Ad-RFP (RFP-expressing
Ad) or EGFP-labeled human cutaneous metastatic melanoma cells were injected im into …